Navigation Links
Arena Pharmaceuticals to Report Fourth Quarter and Full Year 2007 Financial Results and to Host Conference Call and Webcast on Wednesday, February 27, 2008
Date:2/20/2008

SAN DIEGO, Feb. 20 /PRNewswire-FirstCall/ -- Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today announced it will report fourth quarter and full year 2007 financial results after the NASDAQ Global Market closes on Wednesday, February 27, 2008. That same afternoon, Jack Lief, Arena's President and Chief Executive Officer, and Robert E. Hoffman, Arena's Vice President, Finance and Chief Financial Officer, will host a conference call at 5:00 p.m. Eastern Time (2:00 p.m. Pacific Time) to discuss the financial results for the fourth quarter and full year 2007 and to provide 2008 financial guidance and a corporate update.

The conference call may be accessed by dialing 866.356.4281 for domestic callers and 617.597.5395 for international callers. Please specify to the operator that you would like to join the "Arena Fourth Quarter and Full Year Earnings Call." The participant code for the call is 19957700. The conference call will be webcast live under the investor relations section of Arena's website at http://www.arenapharm.com, and will be archived there for 30 days following the call. Please connect to Arena's website several minutes prior to the start of the broadcast to ensure adequate time for any software download that may be necessary.

About Arena Pharmaceuticals

Arena is a clinical-stage biopharmaceutical company focused on discovering, developing and commercializing oral drugs in four major therapeutic areas: cardiovascular, central nervous system, inflammatory and metabolic diseases. Arena's most advanced drug candidate, lorcaserin, is being investigated in a Phase 3 clinical trial program for the treatment of obesity. Arena's broad pipeline of novel compounds tar
'/>"/>

SOURCE Arena Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Arena Pharmaceuticals to Present at the BIO CEO & Investor Conference
2. Arena Pharmaceuticals Announces Initiation of Phase 1 Clinical Trial of Second Generation Niacin Receptor Agonist Under Its Collaboration With Merck & Co., Inc.
3. Arena Pharmaceuticals Enters Into Strategic Agreements for the Manufacture of Pharmaceutical Material, Including Lorcaserin
4. Arena Pharmaceuticals Initiates Second and Third Pivotal Trials Evaluating Lorcaserin for the Treatment of Obesity
5. Arena Pharmaceuticals Appoints Phillip M. Schneider and Randall E. Woods to Board of Directors
6. Arena Pharmaceuticals to Present at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
7. Arena Pharmaceuticals Announces Third Quarter 2007 Financial Results
8. Arena Pharmaceuticals to Report Third Quarter 2007 Financial Results and to Host Conference Call and Webcast on Wednesday, October 17, 2007
9. Arena Pharmaceuticals to Present at Two Upcoming Investor Conferences
10. Arena Pharmaceuticals Selected to Join New NASDAQ NeuroInsights Neurotech Index
11. Arena Pharmaceuticals Continues Phase 3 BLOOM Obesity Trial Following Independent Echocardiographic Data Safety Monitoring Board Review

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...D CITY, Calif., Nov. 24 ...ced that Randy Scott, Genomic Health,s Executive C...fray Health Care Conference in New York City on Tu...o access the live and subsequently archived webcas...s section of Genomic Health,s website at http://i...
(Date:11/24/2009)... Program Connects Customers with Partners Val...th DNA Genotek Products , ...tek , a leading provider of products for biologica..., today announced its new global partner program. ...A Genotek,s partner community and is designed to h...
(Date:11/24/2009)...TLE, Nov. 24 Cell Therap...nt will present at the 21st Annual Piper Jaffray H... December 1-2, 2009, at the New York Palace Hotel....t 11:00 a.m. Eastern Time in Holmes 1 (4th Floor)....e available at www.celltherapeutics.com , and it ...
(Date:11/23/2009)...ou can think of it as origami very high-tech orig...have developed a technique for fabricating three-d...from thin films by coupling photolithography and a...ions. , The films, only a few microns thick, offe... thicker pieces of the same material. , "This is ...
Breaking Biology Technology:Genomic Health to Present at Piper Jaffray Health Care Conference 2DNA Genotek Launches Global Partner Program 2DNA Genotek Launches Global Partner Program 3Water droplets direct self-assembly process in thin-film materials 2
...tients could cut their total,mortality by a fifth ...,according to a new study presented today at the A...shed simultaneously in the New England,Journal of ...pertension in the,Very Elderly Trial (HYVET), whic...ege London, is the largest ever clinical trial to ...
...cts,Group, Inc. (PHPG) today reported its consolid...ar which ended December 31, 2007., Revenues in fi...%,compared with $13,921,000 last year. Order intak... as was our year-end backlog of $9,672,000, up,34....come for the year was $2,130,000 compared to $793,...
...(OTC:,NNLX - News) a nano-biotechnology company is...ny events:, NanoLogix personnel are manning a boo...tion Expo in Sacramento this week, with the compan...ovak. Mr. Hartman will be,presenting in the Exhibi...Biohydrogen and Electricity Production from Waste ...
Other Biology Technology:Significant Reductions in Mortality and Cardiovascular Events Shown Using Blood Pressure-Lowering Treatment in Those Aged 80 and Over 2Significant Reductions in Mortality and Cardiovascular Events Shown Using Blood Pressure-Lowering Treatment in Those Aged 80 and Over 3Significant Reductions in Mortality and Cardiovascular Events Shown Using Blood Pressure-Lowering Treatment in Those Aged 80 and Over 4Photonic Products Group, Inc. Reports Record Financial Results for FY 2007 2Photonic Products Group, Inc. Reports Record Financial Results for FY 2007 3Photonic Products Group, Inc. Reports Record Financial Results for FY 2007 4Photonic Products Group, Inc. Reports Record Financial Results for FY 2007 5Photonic Products Group, Inc. Reports Record Financial Results for FY 2007 6Photonic Products Group, Inc. Reports Record Financial Results for FY 2007 7Photonic Products Group, Inc. Reports Record Financial Results for FY 2007 8Photonic Products Group, Inc. Reports Record Financial Results for FY 2007 9NanoLogix Inc. Presents at the National Hydrogen Association Conference & Provides Operations, Management and Director Update 2NanoLogix Inc. Presents at the National Hydrogen Association Conference & Provides Operations, Management and Director Update 3
(Date:11/25/2009)..., MADISON, WI, NOVEMBER 25, 2009 Soil is the lin...ere, and hydrosphere meet. Despite that, many stud...ts, but nothing more. Soil science educators are c...e public recognize the critical importance of soil...by soil science and earth science teachers at Univ...
(Date:11/24/2009)..., The Lupus Research Institute (LRI) today named ...ling $3.6 million, recognize innovative work acros...ected for their creativity, novelty, and potential...nt, treat, and cure the complex disease of systemi...tablished lupus researchers across the nation and ...
(Date:11/24/2009)..., Springer and the American College of Medical To...orate on the publication of the Journal of Medica...CMT, beginning in March 2010. It was previously p... , The Journal of Medical Toxicology , an inter...dvancing the science and practice of medical toxic...
Breaking Biology News(10 mins):It's not just dirt! 2Lupus Research Institute announces 2009 novel research grants 2Lupus Research Institute announces 2009 novel research grants 3Springer and the American College of Medical Toxicology to work together 2United States Patent and Trademark Office Publishes Stemedica 26apos 3Bs Patent Application for the Treatment of Diabetic Retinopathy 13878 1United States Patent and Trademark Office Publishes Stemedica 26apos 3Bs Patent Application for the Treatment of Diabetic Retinopathy 13878 2United States Patent and Trademark Office Publishes Stemedica 26apos 3Bs Patent Application for the Treatment of Diabetic Retinopathy 13878 3Electronic Cigarette Known as ecig Helps You Quit Smoking 56349 1Electronic Cigarette Known as ecig Helps You Quit Smoking 56349 2Electronic Cigarette Known as ecig Helps You Quit Smoking 56349 3Prevent periodontitis to reduce the risk of head and neck cancer 9821 1Prevent periodontitis to reduce the risk of head and neck cancer 9821 2
...entified a highly potent toxin that causes severe ...ng. , The toxin, produced by certain strains of E...for an outbreak of haemolytic uraemic syndrome, a ..., in South Australia in 1998. , The research t...ty of Adelaide, and included scientists from Monas...
...ins, High Throughput Biology Center have invented ...to help identify otherwise elusive disease-causing...lieved to be "junk." , A variety of DNA microarray...TIP-chip (transposable element insertion point) ca...es have landed and disrupted normal gene function....
...cold air but not when diving in chilly water, a fi...eal to conserve oxygen and minimize brain damage t...s presented the study at The American Physiologica...6: Integrating Diversity," in Virginia Beach, Va.,...lix, Petter H. Kvadsheim and Lars P. Folkow hail f...
Other Biology News:Taking 'chips' to the next level of gene hunting 2Taking 'chips' to the next level of gene hunting 3Seals protect brain, conserve oxygen by turning off shivering response on icy dives 2Seals protect brain, conserve oxygen by turning off shivering response on icy dives 3
Propidium Iodide Staining Solution Solution from BD Biosciences Pharmingen
BD Falcon Easy Grip Cell Culture Dish from BD Biosciences - Discovery Labware
...olymerase is a premium quality recombinant form of...le enzyme is suitable for a wide range of PCR appl...cible performance, each preparation is extensively...vaTaq DNA Polymerase possesses an integral 5′...
... a direct antibiotic-based selection system for re...pends solely on colony survival, eliminating the n...xpensive process provides close to 100% accuracy i...eal platform for robot colony picking. This clonin...
Biology Products: